Jordan Thomas Email & Phone Number

Liverpool, GB

London, England, United Kingdom

Liverpool, England, United Kingdom

Using pseudo-typed virus particle assays to measure neutralising antibody responses against SARS-CoV-2. Developing virus like particle assays to measure protein interactions of SARS-CoV-2.Development of assays to quantify host and viral disease markers using a novel digital PCR platform. Collaboration with industrial start-up (Blink-DX, Germany) developing.

Institute Of Infection And Global Health, University Of Liverpool

Researching HIV-1 persistence and the dynamics of the latent reservoir in the context of therapeutic vaccination. Project aims to develop HIV-1 DNA and RNA quantification assays to measure ultra-low HIV-1 copy numbers from clinical samples. Techniques:- HIV-1 infection assays- Category III containment trained- Tissue culture- qPCR- PCR- Molecular biology.

Liverpool, United Kingdom

Liverpool, United Kingdom

Developing and optimizing the production of pseudo-typed virus particles with Flavivirus (Zika, Dengue) envelopes. Aim to use these particles to develop a neutralization assay for Flaviviruses. Techniques:- Molecular biology- Tissue culture- Pseudovirus production

Bangkok, Thailand

Studying the molecular genetics of HPV and investigating markers for disease outcome, including integration of the viral genome into the host genome in high risk HPV sub-types (HPV16/18). Techniques:- Molecular biology- Tissue Culture- Pyrosequencing

Doctor Of Philosophy (Ph.D.), Virology

Researching HIV-1 persistence in the context of therapeutic vaccination. Developing HIV-1 DNA and RNA quantification assays to measure.

Master’S Degree, Microbiology, General, 1St Class

Thesis title: "Optimisation of an HIV-1 transcytosis model system and generation of fluorescent labelled pseudo-typed virus particles".

Bachelor’S Degree, Microbiology, General, 1St Class

Honours project title: "Investigating expression of Pgd, a novel biofilm regulator of Staphylococcus aureus" Dissertation title: "The.